Could A New COVID-19 Treatment Be The Answer To Combating The Pandemic In Africa? 27/04/2021 Geoffrey Kamadi NAIROBI – A new drug combination therapy to fight COVID-19, unveiled on Tuesday, will be tested in a multi-country clinical trial that is already ongoing in Africa. The drugs nitazoxanide and ciclesonide will be used in the ANTICOV clinical trials testing treatments for mild to moderate COVID cases across groups in 13 African countries. A […] Continue reading -> European Union Sues AstraZeneca Over Delayed Coronavirus Vaccine Deliveries 27/04/2021 Chandre Prince The European Union (EU) is suing coronavirus vaccine manufacturer AstraZeneca over an alleged breach of its vaccine supply contract and for not having a “reliable” plan to ensure timely deliveries. The European Commission – the EU’s executive branch – said the legal action emanates from a longstanding dispute over shortfall in vaccine deliveries. The 27 […] Continue reading -> Pharmaceutical Industry Launches Document on IP Principles Amid Push for TRIPS Waiver 26/04/2021 Kerry Cullinan Amid a huge global push for the World Trade Organization (WTO) to waive intellectual property (IP) rights on products related to COVID-19 for the duration of the pandemic, the pharmaceutical industry launched a document on Monday – World IP Day – asserting that a “strong IP system advances public health” . According to the 10-point […] Continue reading -> Ambitious Push to Resume Routine Immunisations to Save 50 Million Lives – COVAX Waits for Indian Vaccines 26/04/2021 Kerry Cullinan Fifty countries have not yet resumed routine immunisations disrupted by the COVID-19 pandemic, affecting 228 million people – mainly children – and there have already been serious measles outbreaks in Yemen, Pakistan and the Democratic Republic of the Congo, according to World Health Organization (WHO) director general Dr Tedros Adhanom Ghebreyusus. To address this, the […] Continue reading -> The ‘Patent Bargain’, Public Good & COVID19 26/04/2021 Priti Patniak/Geneva Health Files As the hotly contested proposal for an IP waiver on COVID-related health products comes up again for debate on Friday, 30 April at the World Trade Organization’s TRIPS Council, legal expert Hyo Yoon Kang looks at the foundations of IP law to challenge “TRIPS waiver” naysayers. Geneva Health Files [GHF]: You have argued that IP […] Continue reading -> ACT-Accelerator Celebrates 1st Anniversary Amid COVID-19 Surge in India 23/04/2021 Kerry Cullinan One of the few silver linings of the COVID-19 pandemic is the unprecedented collaboration of every sector of society to overcome it – best demonstrated by the Access to COVID-19 Tools Accelerator (ACT-Accelerator), which celebrated its first anniversary on Friday. The ACT-Accelerator’s most famous pillar is the vaccine facility, COVAX, which has distributed almost 40 […] Continue reading -> UK Study Shows Similar, Significant Reductions In COVID-19 Infections With Single Dose Of Oxford-AstraZeneca Or Pfizer-BioNTech Vaccine 23/04/2021 Raisa Santos COVID-19 infections fell significantly – by 65% percent – after a first dose of either the Oxford-AstraZeneca or the Pfizer-BioNTech vaccine in a study of more than 373,000 British residents who received one of the two jabs. The first in a series of two new studies, published by the University of Oxford, found that the […] Continue reading -> Pakistan Quietly Suspends Vaccination Of Healthcare Workers – Then Abruptly Resumes Following Media Queries 21/04/2021 Rahul Basharat Rajput & Muhammed Nadeem Chaudhry Islamabad, Pakistan: Even as Pakistan faced an intense third wave of COVID-19, health authorities ‘silently’ suspended vaccination registration for its frontline Healthcare Workers (HCWs) for more than a month – ostensibly because of low registration and concerns about fake registrations. But following queries by Health Policy Watch on Monday, Ministry of Health officials suddenly did […] Continue reading -> European Medicines Agency Reaffirms Benefits Of Johnson & Johnson Vaccine 21/04/2021 Chandre Prince There is a “possible link” between the Johnson & Johnson COVID-19 vaccine and very rare cases of blood clots, but the benefits of the single-dose vaccine outweigh the risks, the European Medicines Agency (EMA) has announced. In a statement released on Tuesday, the EMA safety committee said that the rare, but serious blood clot disorders, […] Continue reading -> As COVID Cases Surge – India Makes US$ 550 Million Investments In Local Vaccine Production & Opens Private Market To Vaccine Imports 20/04/2021 Menaka Rao DELHI – In a twin bid to get ahead of a surging COVID-19 epidemic, the Indian government said that it will make “advance payments” totally some US$ 550 million to domestic COVID-19 vaccine makers – as well as opening up the market to private sector import and sales of other approved COVID-19 vaccines. Under the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
European Union Sues AstraZeneca Over Delayed Coronavirus Vaccine Deliveries 27/04/2021 Chandre Prince The European Union (EU) is suing coronavirus vaccine manufacturer AstraZeneca over an alleged breach of its vaccine supply contract and for not having a “reliable” plan to ensure timely deliveries. The European Commission – the EU’s executive branch – said the legal action emanates from a longstanding dispute over shortfall in vaccine deliveries. The 27 […] Continue reading -> Pharmaceutical Industry Launches Document on IP Principles Amid Push for TRIPS Waiver 26/04/2021 Kerry Cullinan Amid a huge global push for the World Trade Organization (WTO) to waive intellectual property (IP) rights on products related to COVID-19 for the duration of the pandemic, the pharmaceutical industry launched a document on Monday – World IP Day – asserting that a “strong IP system advances public health” . According to the 10-point […] Continue reading -> Ambitious Push to Resume Routine Immunisations to Save 50 Million Lives – COVAX Waits for Indian Vaccines 26/04/2021 Kerry Cullinan Fifty countries have not yet resumed routine immunisations disrupted by the COVID-19 pandemic, affecting 228 million people – mainly children – and there have already been serious measles outbreaks in Yemen, Pakistan and the Democratic Republic of the Congo, according to World Health Organization (WHO) director general Dr Tedros Adhanom Ghebreyusus. To address this, the […] Continue reading -> The ‘Patent Bargain’, Public Good & COVID19 26/04/2021 Priti Patniak/Geneva Health Files As the hotly contested proposal for an IP waiver on COVID-related health products comes up again for debate on Friday, 30 April at the World Trade Organization’s TRIPS Council, legal expert Hyo Yoon Kang looks at the foundations of IP law to challenge “TRIPS waiver” naysayers. Geneva Health Files [GHF]: You have argued that IP […] Continue reading -> ACT-Accelerator Celebrates 1st Anniversary Amid COVID-19 Surge in India 23/04/2021 Kerry Cullinan One of the few silver linings of the COVID-19 pandemic is the unprecedented collaboration of every sector of society to overcome it – best demonstrated by the Access to COVID-19 Tools Accelerator (ACT-Accelerator), which celebrated its first anniversary on Friday. The ACT-Accelerator’s most famous pillar is the vaccine facility, COVAX, which has distributed almost 40 […] Continue reading -> UK Study Shows Similar, Significant Reductions In COVID-19 Infections With Single Dose Of Oxford-AstraZeneca Or Pfizer-BioNTech Vaccine 23/04/2021 Raisa Santos COVID-19 infections fell significantly – by 65% percent – after a first dose of either the Oxford-AstraZeneca or the Pfizer-BioNTech vaccine in a study of more than 373,000 British residents who received one of the two jabs. The first in a series of two new studies, published by the University of Oxford, found that the […] Continue reading -> Pakistan Quietly Suspends Vaccination Of Healthcare Workers – Then Abruptly Resumes Following Media Queries 21/04/2021 Rahul Basharat Rajput & Muhammed Nadeem Chaudhry Islamabad, Pakistan: Even as Pakistan faced an intense third wave of COVID-19, health authorities ‘silently’ suspended vaccination registration for its frontline Healthcare Workers (HCWs) for more than a month – ostensibly because of low registration and concerns about fake registrations. But following queries by Health Policy Watch on Monday, Ministry of Health officials suddenly did […] Continue reading -> European Medicines Agency Reaffirms Benefits Of Johnson & Johnson Vaccine 21/04/2021 Chandre Prince There is a “possible link” between the Johnson & Johnson COVID-19 vaccine and very rare cases of blood clots, but the benefits of the single-dose vaccine outweigh the risks, the European Medicines Agency (EMA) has announced. In a statement released on Tuesday, the EMA safety committee said that the rare, but serious blood clot disorders, […] Continue reading -> As COVID Cases Surge – India Makes US$ 550 Million Investments In Local Vaccine Production & Opens Private Market To Vaccine Imports 20/04/2021 Menaka Rao DELHI – In a twin bid to get ahead of a surging COVID-19 epidemic, the Indian government said that it will make “advance payments” totally some US$ 550 million to domestic COVID-19 vaccine makers – as well as opening up the market to private sector import and sales of other approved COVID-19 vaccines. Under the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pharmaceutical Industry Launches Document on IP Principles Amid Push for TRIPS Waiver 26/04/2021 Kerry Cullinan Amid a huge global push for the World Trade Organization (WTO) to waive intellectual property (IP) rights on products related to COVID-19 for the duration of the pandemic, the pharmaceutical industry launched a document on Monday – World IP Day – asserting that a “strong IP system advances public health” . According to the 10-point […] Continue reading -> Ambitious Push to Resume Routine Immunisations to Save 50 Million Lives – COVAX Waits for Indian Vaccines 26/04/2021 Kerry Cullinan Fifty countries have not yet resumed routine immunisations disrupted by the COVID-19 pandemic, affecting 228 million people – mainly children – and there have already been serious measles outbreaks in Yemen, Pakistan and the Democratic Republic of the Congo, according to World Health Organization (WHO) director general Dr Tedros Adhanom Ghebreyusus. To address this, the […] Continue reading -> The ‘Patent Bargain’, Public Good & COVID19 26/04/2021 Priti Patniak/Geneva Health Files As the hotly contested proposal for an IP waiver on COVID-related health products comes up again for debate on Friday, 30 April at the World Trade Organization’s TRIPS Council, legal expert Hyo Yoon Kang looks at the foundations of IP law to challenge “TRIPS waiver” naysayers. Geneva Health Files [GHF]: You have argued that IP […] Continue reading -> ACT-Accelerator Celebrates 1st Anniversary Amid COVID-19 Surge in India 23/04/2021 Kerry Cullinan One of the few silver linings of the COVID-19 pandemic is the unprecedented collaboration of every sector of society to overcome it – best demonstrated by the Access to COVID-19 Tools Accelerator (ACT-Accelerator), which celebrated its first anniversary on Friday. The ACT-Accelerator’s most famous pillar is the vaccine facility, COVAX, which has distributed almost 40 […] Continue reading -> UK Study Shows Similar, Significant Reductions In COVID-19 Infections With Single Dose Of Oxford-AstraZeneca Or Pfizer-BioNTech Vaccine 23/04/2021 Raisa Santos COVID-19 infections fell significantly – by 65% percent – after a first dose of either the Oxford-AstraZeneca or the Pfizer-BioNTech vaccine in a study of more than 373,000 British residents who received one of the two jabs. The first in a series of two new studies, published by the University of Oxford, found that the […] Continue reading -> Pakistan Quietly Suspends Vaccination Of Healthcare Workers – Then Abruptly Resumes Following Media Queries 21/04/2021 Rahul Basharat Rajput & Muhammed Nadeem Chaudhry Islamabad, Pakistan: Even as Pakistan faced an intense third wave of COVID-19, health authorities ‘silently’ suspended vaccination registration for its frontline Healthcare Workers (HCWs) for more than a month – ostensibly because of low registration and concerns about fake registrations. But following queries by Health Policy Watch on Monday, Ministry of Health officials suddenly did […] Continue reading -> European Medicines Agency Reaffirms Benefits Of Johnson & Johnson Vaccine 21/04/2021 Chandre Prince There is a “possible link” between the Johnson & Johnson COVID-19 vaccine and very rare cases of blood clots, but the benefits of the single-dose vaccine outweigh the risks, the European Medicines Agency (EMA) has announced. In a statement released on Tuesday, the EMA safety committee said that the rare, but serious blood clot disorders, […] Continue reading -> As COVID Cases Surge – India Makes US$ 550 Million Investments In Local Vaccine Production & Opens Private Market To Vaccine Imports 20/04/2021 Menaka Rao DELHI – In a twin bid to get ahead of a surging COVID-19 epidemic, the Indian government said that it will make “advance payments” totally some US$ 550 million to domestic COVID-19 vaccine makers – as well as opening up the market to private sector import and sales of other approved COVID-19 vaccines. Under the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Ambitious Push to Resume Routine Immunisations to Save 50 Million Lives – COVAX Waits for Indian Vaccines 26/04/2021 Kerry Cullinan Fifty countries have not yet resumed routine immunisations disrupted by the COVID-19 pandemic, affecting 228 million people – mainly children – and there have already been serious measles outbreaks in Yemen, Pakistan and the Democratic Republic of the Congo, according to World Health Organization (WHO) director general Dr Tedros Adhanom Ghebreyusus. To address this, the […] Continue reading -> The ‘Patent Bargain’, Public Good & COVID19 26/04/2021 Priti Patniak/Geneva Health Files As the hotly contested proposal for an IP waiver on COVID-related health products comes up again for debate on Friday, 30 April at the World Trade Organization’s TRIPS Council, legal expert Hyo Yoon Kang looks at the foundations of IP law to challenge “TRIPS waiver” naysayers. Geneva Health Files [GHF]: You have argued that IP […] Continue reading -> ACT-Accelerator Celebrates 1st Anniversary Amid COVID-19 Surge in India 23/04/2021 Kerry Cullinan One of the few silver linings of the COVID-19 pandemic is the unprecedented collaboration of every sector of society to overcome it – best demonstrated by the Access to COVID-19 Tools Accelerator (ACT-Accelerator), which celebrated its first anniversary on Friday. The ACT-Accelerator’s most famous pillar is the vaccine facility, COVAX, which has distributed almost 40 […] Continue reading -> UK Study Shows Similar, Significant Reductions In COVID-19 Infections With Single Dose Of Oxford-AstraZeneca Or Pfizer-BioNTech Vaccine 23/04/2021 Raisa Santos COVID-19 infections fell significantly – by 65% percent – after a first dose of either the Oxford-AstraZeneca or the Pfizer-BioNTech vaccine in a study of more than 373,000 British residents who received one of the two jabs. The first in a series of two new studies, published by the University of Oxford, found that the […] Continue reading -> Pakistan Quietly Suspends Vaccination Of Healthcare Workers – Then Abruptly Resumes Following Media Queries 21/04/2021 Rahul Basharat Rajput & Muhammed Nadeem Chaudhry Islamabad, Pakistan: Even as Pakistan faced an intense third wave of COVID-19, health authorities ‘silently’ suspended vaccination registration for its frontline Healthcare Workers (HCWs) for more than a month – ostensibly because of low registration and concerns about fake registrations. But following queries by Health Policy Watch on Monday, Ministry of Health officials suddenly did […] Continue reading -> European Medicines Agency Reaffirms Benefits Of Johnson & Johnson Vaccine 21/04/2021 Chandre Prince There is a “possible link” between the Johnson & Johnson COVID-19 vaccine and very rare cases of blood clots, but the benefits of the single-dose vaccine outweigh the risks, the European Medicines Agency (EMA) has announced. In a statement released on Tuesday, the EMA safety committee said that the rare, but serious blood clot disorders, […] Continue reading -> As COVID Cases Surge – India Makes US$ 550 Million Investments In Local Vaccine Production & Opens Private Market To Vaccine Imports 20/04/2021 Menaka Rao DELHI – In a twin bid to get ahead of a surging COVID-19 epidemic, the Indian government said that it will make “advance payments” totally some US$ 550 million to domestic COVID-19 vaccine makers – as well as opening up the market to private sector import and sales of other approved COVID-19 vaccines. Under the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
The ‘Patent Bargain’, Public Good & COVID19 26/04/2021 Priti Patniak/Geneva Health Files As the hotly contested proposal for an IP waiver on COVID-related health products comes up again for debate on Friday, 30 April at the World Trade Organization’s TRIPS Council, legal expert Hyo Yoon Kang looks at the foundations of IP law to challenge “TRIPS waiver” naysayers. Geneva Health Files [GHF]: You have argued that IP […] Continue reading -> ACT-Accelerator Celebrates 1st Anniversary Amid COVID-19 Surge in India 23/04/2021 Kerry Cullinan One of the few silver linings of the COVID-19 pandemic is the unprecedented collaboration of every sector of society to overcome it – best demonstrated by the Access to COVID-19 Tools Accelerator (ACT-Accelerator), which celebrated its first anniversary on Friday. The ACT-Accelerator’s most famous pillar is the vaccine facility, COVAX, which has distributed almost 40 […] Continue reading -> UK Study Shows Similar, Significant Reductions In COVID-19 Infections With Single Dose Of Oxford-AstraZeneca Or Pfizer-BioNTech Vaccine 23/04/2021 Raisa Santos COVID-19 infections fell significantly – by 65% percent – after a first dose of either the Oxford-AstraZeneca or the Pfizer-BioNTech vaccine in a study of more than 373,000 British residents who received one of the two jabs. The first in a series of two new studies, published by the University of Oxford, found that the […] Continue reading -> Pakistan Quietly Suspends Vaccination Of Healthcare Workers – Then Abruptly Resumes Following Media Queries 21/04/2021 Rahul Basharat Rajput & Muhammed Nadeem Chaudhry Islamabad, Pakistan: Even as Pakistan faced an intense third wave of COVID-19, health authorities ‘silently’ suspended vaccination registration for its frontline Healthcare Workers (HCWs) for more than a month – ostensibly because of low registration and concerns about fake registrations. But following queries by Health Policy Watch on Monday, Ministry of Health officials suddenly did […] Continue reading -> European Medicines Agency Reaffirms Benefits Of Johnson & Johnson Vaccine 21/04/2021 Chandre Prince There is a “possible link” between the Johnson & Johnson COVID-19 vaccine and very rare cases of blood clots, but the benefits of the single-dose vaccine outweigh the risks, the European Medicines Agency (EMA) has announced. In a statement released on Tuesday, the EMA safety committee said that the rare, but serious blood clot disorders, […] Continue reading -> As COVID Cases Surge – India Makes US$ 550 Million Investments In Local Vaccine Production & Opens Private Market To Vaccine Imports 20/04/2021 Menaka Rao DELHI – In a twin bid to get ahead of a surging COVID-19 epidemic, the Indian government said that it will make “advance payments” totally some US$ 550 million to domestic COVID-19 vaccine makers – as well as opening up the market to private sector import and sales of other approved COVID-19 vaccines. Under the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
ACT-Accelerator Celebrates 1st Anniversary Amid COVID-19 Surge in India 23/04/2021 Kerry Cullinan One of the few silver linings of the COVID-19 pandemic is the unprecedented collaboration of every sector of society to overcome it – best demonstrated by the Access to COVID-19 Tools Accelerator (ACT-Accelerator), which celebrated its first anniversary on Friday. The ACT-Accelerator’s most famous pillar is the vaccine facility, COVAX, which has distributed almost 40 […] Continue reading -> UK Study Shows Similar, Significant Reductions In COVID-19 Infections With Single Dose Of Oxford-AstraZeneca Or Pfizer-BioNTech Vaccine 23/04/2021 Raisa Santos COVID-19 infections fell significantly – by 65% percent – after a first dose of either the Oxford-AstraZeneca or the Pfizer-BioNTech vaccine in a study of more than 373,000 British residents who received one of the two jabs. The first in a series of two new studies, published by the University of Oxford, found that the […] Continue reading -> Pakistan Quietly Suspends Vaccination Of Healthcare Workers – Then Abruptly Resumes Following Media Queries 21/04/2021 Rahul Basharat Rajput & Muhammed Nadeem Chaudhry Islamabad, Pakistan: Even as Pakistan faced an intense third wave of COVID-19, health authorities ‘silently’ suspended vaccination registration for its frontline Healthcare Workers (HCWs) for more than a month – ostensibly because of low registration and concerns about fake registrations. But following queries by Health Policy Watch on Monday, Ministry of Health officials suddenly did […] Continue reading -> European Medicines Agency Reaffirms Benefits Of Johnson & Johnson Vaccine 21/04/2021 Chandre Prince There is a “possible link” between the Johnson & Johnson COVID-19 vaccine and very rare cases of blood clots, but the benefits of the single-dose vaccine outweigh the risks, the European Medicines Agency (EMA) has announced. In a statement released on Tuesday, the EMA safety committee said that the rare, but serious blood clot disorders, […] Continue reading -> As COVID Cases Surge – India Makes US$ 550 Million Investments In Local Vaccine Production & Opens Private Market To Vaccine Imports 20/04/2021 Menaka Rao DELHI – In a twin bid to get ahead of a surging COVID-19 epidemic, the Indian government said that it will make “advance payments” totally some US$ 550 million to domestic COVID-19 vaccine makers – as well as opening up the market to private sector import and sales of other approved COVID-19 vaccines. Under the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
UK Study Shows Similar, Significant Reductions In COVID-19 Infections With Single Dose Of Oxford-AstraZeneca Or Pfizer-BioNTech Vaccine 23/04/2021 Raisa Santos COVID-19 infections fell significantly – by 65% percent – after a first dose of either the Oxford-AstraZeneca or the Pfizer-BioNTech vaccine in a study of more than 373,000 British residents who received one of the two jabs. The first in a series of two new studies, published by the University of Oxford, found that the […] Continue reading -> Pakistan Quietly Suspends Vaccination Of Healthcare Workers – Then Abruptly Resumes Following Media Queries 21/04/2021 Rahul Basharat Rajput & Muhammed Nadeem Chaudhry Islamabad, Pakistan: Even as Pakistan faced an intense third wave of COVID-19, health authorities ‘silently’ suspended vaccination registration for its frontline Healthcare Workers (HCWs) for more than a month – ostensibly because of low registration and concerns about fake registrations. But following queries by Health Policy Watch on Monday, Ministry of Health officials suddenly did […] Continue reading -> European Medicines Agency Reaffirms Benefits Of Johnson & Johnson Vaccine 21/04/2021 Chandre Prince There is a “possible link” between the Johnson & Johnson COVID-19 vaccine and very rare cases of blood clots, but the benefits of the single-dose vaccine outweigh the risks, the European Medicines Agency (EMA) has announced. In a statement released on Tuesday, the EMA safety committee said that the rare, but serious blood clot disorders, […] Continue reading -> As COVID Cases Surge – India Makes US$ 550 Million Investments In Local Vaccine Production & Opens Private Market To Vaccine Imports 20/04/2021 Menaka Rao DELHI – In a twin bid to get ahead of a surging COVID-19 epidemic, the Indian government said that it will make “advance payments” totally some US$ 550 million to domestic COVID-19 vaccine makers – as well as opening up the market to private sector import and sales of other approved COVID-19 vaccines. Under the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pakistan Quietly Suspends Vaccination Of Healthcare Workers – Then Abruptly Resumes Following Media Queries 21/04/2021 Rahul Basharat Rajput & Muhammed Nadeem Chaudhry Islamabad, Pakistan: Even as Pakistan faced an intense third wave of COVID-19, health authorities ‘silently’ suspended vaccination registration for its frontline Healthcare Workers (HCWs) for more than a month – ostensibly because of low registration and concerns about fake registrations. But following queries by Health Policy Watch on Monday, Ministry of Health officials suddenly did […] Continue reading -> European Medicines Agency Reaffirms Benefits Of Johnson & Johnson Vaccine 21/04/2021 Chandre Prince There is a “possible link” between the Johnson & Johnson COVID-19 vaccine and very rare cases of blood clots, but the benefits of the single-dose vaccine outweigh the risks, the European Medicines Agency (EMA) has announced. In a statement released on Tuesday, the EMA safety committee said that the rare, but serious blood clot disorders, […] Continue reading -> As COVID Cases Surge – India Makes US$ 550 Million Investments In Local Vaccine Production & Opens Private Market To Vaccine Imports 20/04/2021 Menaka Rao DELHI – In a twin bid to get ahead of a surging COVID-19 epidemic, the Indian government said that it will make “advance payments” totally some US$ 550 million to domestic COVID-19 vaccine makers – as well as opening up the market to private sector import and sales of other approved COVID-19 vaccines. Under the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
European Medicines Agency Reaffirms Benefits Of Johnson & Johnson Vaccine 21/04/2021 Chandre Prince There is a “possible link” between the Johnson & Johnson COVID-19 vaccine and very rare cases of blood clots, but the benefits of the single-dose vaccine outweigh the risks, the European Medicines Agency (EMA) has announced. In a statement released on Tuesday, the EMA safety committee said that the rare, but serious blood clot disorders, […] Continue reading -> As COVID Cases Surge – India Makes US$ 550 Million Investments In Local Vaccine Production & Opens Private Market To Vaccine Imports 20/04/2021 Menaka Rao DELHI – In a twin bid to get ahead of a surging COVID-19 epidemic, the Indian government said that it will make “advance payments” totally some US$ 550 million to domestic COVID-19 vaccine makers – as well as opening up the market to private sector import and sales of other approved COVID-19 vaccines. Under the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
As COVID Cases Surge – India Makes US$ 550 Million Investments In Local Vaccine Production & Opens Private Market To Vaccine Imports 20/04/2021 Menaka Rao DELHI – In a twin bid to get ahead of a surging COVID-19 epidemic, the Indian government said that it will make “advance payments” totally some US$ 550 million to domestic COVID-19 vaccine makers – as well as opening up the market to private sector import and sales of other approved COVID-19 vaccines. Under the […] Continue reading -> Posts navigation Older postsNewer posts